| How often do you identify patients in need of follow-up cancer care in your practice by: | | | |
| Reaching out to the patients with cancer through written communication or telephone, and encouraging them to contact the practice if necessary? | 40 (23.1) | 62 (35.8) | 71 (41.0) |
| Contacting patients through written communication or by telephone to offer consultation in practice? | 45 (26.0) | 65 (37.6) | 63 (36.4) |
| Receiving information through discharge cards or by telephone from the hospital regarding patients’ requiring follow-up? | 35 (20.2) | 53 (30.6) | 85 (49.1) |
| Receiving information through written communication or telephone from the patients’ home municipality? | 80 (46.2) | 49 (28.3) | 44 (25.4) |
| Being contacted in writing or by telephone by a patient or relative? | 18 (10.4) | 74 (42.8) | 81 (46.8) |
|
Not at all or very low or low
n
(%)
|
Somewhat
n
(%)
|
Highly or very highly
n
(%)
|
| To what extent do you feel qualified to assess the following possible sequelae after the patients’ cancer diagnosis and treatment: | | | |
| Other somatic disease and treatment? | 5 (2.9) | 66 (38.2) | 102 (59.0) |
| Physical sequelae | 17 (9.8) | 99 (57.2) | 57 (32.9) |
| Challenges and problems related to sexuality and intimacy? | 52 (30.1) | 88 (50.9) | 33 (19.1) |
| Mental sequelae? | 3 (1.7) | 49 (28.3) | 121 (69.9) |
| Social consequences? | 27 (15.6) | 79 (45.7) | 67 (38.7) |
| Existential considerations? | 19 (11.0) | 66 (38.2) | 88 (50.9) |
| Challenges and lifestyle-related issues? | 6 (3.5) | 58 (33.5) | 109 (63.0) |
| To what extent does the written information you receive from specialised hospital departments met your need for knowledge about: | | | |
| The patient’s cancer diagnosis? | 11 (6.4) | 49 (28.3) | 113 (65.3) |
| The patient’s cancer treatment? | 28 (16.2) | 75 (43.4) | 70 (40.5) |
| Possible side effects and long-term effects of the patient’s cancer diagnosis and treatment? | 113 (65.3) | 46 (26.6) | 14 (8.1) |
| Who is responsible for cancer follow-up? | 67 (38.7) | 73 (42.2) | 33 (19.1) |